Russell Investments Group Ltd. Has $51.57 Million Stake in Monsanto Company (MON)
Russell Investments Group Ltd. lowered its stake in shares of Monsanto Company (NYSE:MON) by 5.9% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 430,517 shares of the basic materials company’s stock after selling 27,042 shares during the period. Russell Investments Group Ltd. owned 0.10% of Monsanto worth $51,574,000 at the end of the most recent quarter.
Several other hedge funds have also bought and sold shares of MON. BlackRock Inc. increased its holdings in shares of Monsanto by 2,390.1% during the 1st quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after acquiring an additional 25,140,936 shares during the last quarter. OZ Management LP acquired a new position in shares of Monsanto during the 2nd quarter worth approximately $242,786,000. York Capital Management Global Advisors LLC increased its holdings in shares of Monsanto by 58.4% during the 1st quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock worth $462,662,000 after acquiring an additional 1,506,057 shares during the last quarter. Janus Henderson Group PLC increased its holdings in shares of Monsanto by 2,540.4% during the 2nd quarter. Janus Henderson Group PLC now owns 1,491,324 shares of the basic materials company’s stock worth $176,515,000 after acquiring an additional 1,434,844 shares during the last quarter. Finally, PSquared Asset Management AG increased its holdings in shares of Monsanto by 239.0% during the 2nd quarter. PSquared Asset Management AG now owns 1,274,320 shares of the basic materials company’s stock worth $150,829,000 after acquiring an additional 898,395 shares during the last quarter. 74.50% of the stock is currently owned by institutional investors and hedge funds.
In other Monsanto news, EVP Steven Mizell sold 11,526 shares of the stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $119.70, for a total value of $1,379,662.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Nicole M. Ringenberg sold 7,890 shares of the stock in a transaction dated Monday, October 16th. The shares were sold at an average price of $122.25, for a total value of $964,552.50. Following the completion of the transaction, the vice president now owns 38,600 shares of the company’s stock, valued at $4,718,850. The disclosure for this sale can be found here. Insiders sold 49,236 shares of company stock valued at $5,931,934 over the last quarter. Corporate insiders own 0.79% of the company’s stock.
MON has been the topic of a number of recent analyst reports. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $131.00 target price on the stock in a report on Tuesday, August 29th. Piper Jaffray Companies set a $128.00 target price on Monsanto and gave the stock a “buy” rating in a report on Friday, August 11th. BMO Capital Markets reissued a “buy” rating and set a $128.00 target price on shares of Monsanto in a report on Friday, September 1st. Barclays PLC reaffirmed an “equal weight” rating and issued a $124.00 price objective (up from $120.00) on shares of Monsanto in a report on Thursday, October 5th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a report on Friday, September 15th. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $124.61.
Shares of Monsanto Company (MON) opened at $118.33 on Friday. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. Monsanto Company has a 1 year low of $100.29 and a 1 year high of $122.79. The firm has a market capitalization of $52,088.87, a price-to-earnings ratio of 21.40, a P/E/G ratio of 1.70 and a beta of 1.05.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, topping the consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 1.24% and a net margin of 0.93%. The business had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same period in the prior year, the company earned $0.07 EPS. Monsanto’s revenue for the quarter was up 4.8% on a year-over-year basis. analysts predict that Monsanto Company will post 5.74 earnings per share for the current year.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.